Deutsche Bank Reiterates Hold, $12 PT On Targacept
In a note out today, Deutsche Bank reiterated a hold rating and $12 price target on biotech firm Targacept (Nasdaq: TRGT). The price target implies roughly 50% upside from current levels. Deutsche Bank said downside in the stock is buffered by the company's $7 per share in cash.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.